Skip to main content
Top

International Journal of Hematology

Issue 2/2021

Content (21 Articles)

Septicemia Original Article

Validation of sepsis-induced coagulopathy score in critically ill patients with septic shock: post hoc analysis of a nationwide multicenter observational study in Japan

Chie Tanaka, Takashi Tagami, Saori Kudo, Akiko Takehara, Reo Fukuda, Fumihiko Nakayama, Junya Kaneko, Yoshito Ishiki, Shin Sato, Masamune Kuno, Kyoko Unemoto

Castleman Disease Original Article

Patient’s age and d-dimer levels predict the prognosis in patients with TAFRO syndrome

Hiroshi Kawabata, Shino Fujimoto, Tomoyuki Sakai, Hiroto Yanagisawa, Toshio Kitawaki, Kenji Nara, Masao Hagihara, Hiroshi Yamamoto, Masakuni Tanimizu, Chikako Kato, Tomoki Origuchi, Kazutaka Sunami, Yoshitaka Sunami, Taro Masunari, Nobuhiko Nakamura, Masanori Kobayashi, Keiko Yamagami, Katsuhiro Miura, Kazue Takai, Sadao Aoki, Norifumi Tsukamoto, Yasufumi Masaki

Rituximab Original Article

Risk stratification model based on VEGF and International Prognostic Index accurately identifies low-risk diffuse large B-cell lymphoma patients in the rituximab era

Wei Sang, Hang Zhou, Yuanyuan Qin, Ziyuan Shen, Dongmei Yan, Cai Sun, Xuguang Song, Yuhan Ma, Dongyun Tu, Zhenzhen Bian, Shanlin Nie, Yingliang Jin, Linyan Xu, Zhenyu Li, Kailin Xu

Efficacy and safety of ponatinib for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: a case series from a single institute

Keisuke Kidoguchi, Hiroshi Ureshino, Haruna Kizuka-Sano, Kyosuke Yamaguchi, Hiroo Katsuya, Yasushi Kubota, Toshihiko Ando, Masatomo Miura, Naoto Takahashi, Shinya Kimura

Lymphoma Original Article

Low absolute lymphocyte count is a poor prognostic factor for untreated advanced follicular lymphoma treated with rituximab plus bendamustine: results of the prospective phase 2 CONVERT trial

Shinya Rai, Hiroaki Inoue, Hitoshi Hanamoto, Mitsuhiro Matsuda, Yasuhiro Maeda, Yusuke Wada, Takahiro Haeno, Yosaku Watatani, Takahiro Kumode, Chikara Hirase, J. Luis Espinoza, Yasuyoshi Morita, Hirokazu Tanaka, Yoichi Tatsumi, Itaru Matsumura

Lymphoma Original Article

Pretreatment levels of serum soluble interleukin-2 receptor are useful in selecting the treatment regimen for newly diagnosed advanced-stage follicular lymphoma with low tumor burden

Kenji Nozaki, Hiroyuki Sugahara, Shuji Ueda, Jun Ishikawa, Takahiro Karasuno, Masato Iida, Tsuyoshi Kamae, Yasuhiro Moriyama, Manabu Kawakami, Satoru Kosugi, Masashi Nakagawa, Yasuhiko Azenishi, Ryoto Sakaniwa, Tetsuhisa Kitamura, Hirohiko Shibayama

Erythropoietin Original Article

Evaluation of beta-2 microglobulin, erythropoietin and tobacco use in polycythemic cases

Kristell Mahe, Francis Couturaud, Hélène Kerspern, Aurélie Chauveau, Jean-Christophe Ianotto

Stem Cell Transplantion Original Article

Eltrombopag for the treatment of poor graft function following allogeneic stem cell transplant: a retrospective multicenter study

Sabrina Giammarco, Simona Sica, Patrizia Chiusolo, Luca Laurenti, Federica Sorá, Massimo Martino, Elisabetta Metafuni, Alessandro Busca, Antonio Risitano, Carlos Vallejo, Andrea Bacigalupo

Filgrastim Original Article

Circulatory miR-155 correlation with platelet and neutrophil recovery after autologous hematopoietic stem cell transplantation, a multivariate analysis

Mohammad Rafiee, Mehdi Allahbakhshian Farsani, Vahid Amiri, Abbas Hajifathali, Ahmad Gharehbaghian, Mohammad Hossein Mohammadi

Prognostic impact of the dosage of methotrexate combined with tacrolimus for graft-versus-host disease prophylaxis after cord blood transplantation

Miwa Adachi, Daisuke Yokota, Hiroya Hirata, Katsumi Koyauchi, Satoshi Dohtan, Shinichiro Oka, Nami Sakamoto, Masamitsu Takaba, Tomonari Takemura, Yasuyuki Nagata, Kensuke Naito, Takaaki Ono

Pneumococcus Original Article

Changes in vaccination strategies contribute to the development of invasive pneumococcal disease in allogeneic hematopoietic stem cell transplantation recipients: a retrospective study for promoting vaccination

Tatsuya Konishi, Noritaka Sekiya, Yuki Otsuka, Ryosuke Konuma, Atsushi Wada, Hiroto Adachi, Yuya Kishida, Akihito Nagata, Yuta Yamada, Yuma Noguchi, Atsushi Marumo, Junichi Mukae, Kyoko Inamoto, Takashi Toya, Aiko Igarashi, Yuho Najima, Takeshi Kobayashi, Hisashi Sakamaki, Kazuteru Ohashi, Noriko Doki

Asian population may have a lower incidence of hip osteonecrosis in childhood acute lymphoblastic leukemia

Yuki Arakawa, Satoshi Masutani, Koichi Oshima, Yuichi Mitani, Makiko Mori, Kohei Fukuoka, Koichi Moriwaki, Motohiro Kato, Katsuaki Taira, Yutaka Tanami, Atsuko Nakazawa, Katsuyoshi Koh

Lymphoma Case Report

Newly diagnosed follicular lymphoma during pembrolizumab treatment for lung cancer

Yoshiaki Marumo, Shigeru Kusumoto, Ayako Masaki, Takahiro Nakashima, Takaki Kikuchi, Fumiko Mori, Hirokazu Komatsu, Hiroshi Inagaki, Shinsuke Iida, Atsushi Inagaki

A novel germline GATA2 frameshift mutation with a premature stop codon in a family with congenital sensory hearing loss and myelodysplastic syndrome

Hideyuki Nakazawa, Tomomi Yamaguchi, Hitoshi Sakai, Masae Maruyama, Toru Kawakami, Fumihiro Kawakami, Sayaka Nishina, Masumi Ishikawa, Tomoki Kosho, Fumihiro Ishida

Anaphylaxis Case Report

Post-transplant food anaphylaxis in an adult cord blood transplant recipient (Ms. No. IJHM-D-20-01037R1)

Ai Kawahara, Tsukasa Nakanishi, Midori Goto, Kenichi Akao, Takefumi Katsuragi, Junichi Tsukada

ETV6-related thrombocytopenia associated with a transient decrease in von Willebrand factor

Yuri Kanamaru, Toru Uchiyama, Tadashi Kaname, Kumiko Yanagi, Osamu Ohara, Shinji Kunishima, Akira Ishiguro

Correction

Correction to: Patient’s age and D‑dimer levels predict the prognosis in patients with TAFRO syndrome

Hiroshi Kawabata, Shino Fujimoto, Tomoyuki Sakai, Hiroto Yanagisawa, Toshio Kitawaki, Kenji Nara, Masao Hagihara, Hiroshi Yamamoto, Masakuni Tanimizu, Chikako Kato, Tomoki Origuchi, Kazutaka Sunami, Yoshitaka Sunami, Taro Masunari, Nobuhiko Nakamura, Masanori Kobayashi, Keiko Yamagami, Katsuhiro Miura, Kazue Takai, Sadao Aoki, Norifumi Tsukamoto, Yasufumi Masaki

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine